These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 8532720

  • 1. A transgenic mouse model (TG.AC) for skin carcinogenesis: inducible transgene expression as a second critical event.
    Hansen LA, Spalding JW, French JE, Tennant RW.
    Prog Clin Biol Res; 1995; 391():223-35. PubMed ID: 8532720
    [Abstract] [Full Text] [Related]

  • 2. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM, Spalding JW, Tennant RW, Smart RC.
    Cancer Res; 1995 Jul 15; 55(14):3171-8. PubMed ID: 7606738
    [Abstract] [Full Text] [Related]

  • 3. Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.
    Zhang Z, Yao R, Li J, Wang Y, Boone CW, Lubet RA, You M.
    Mol Cancer Res; 2005 Oct 15; 3(10):563-74. PubMed ID: 16254190
    [Abstract] [Full Text] [Related]

  • 4. Biological, cellular, and molecular characteristics of an inducible transgenic skin tumor model: a review.
    Humble MC, Trempus CS, Spalding JW, Cannon RE, Tennant RW.
    Oncogene; 2005 Dec 15; 24(56):8217-28. PubMed ID: 16355251
    [Abstract] [Full Text] [Related]

  • 5. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice.
    Tober KL, Cannon RE, Spalding JW, Oberyszyn TM, Parrett ML, Rackoff AI, Oberyszyn AS, Tennant RW, Robertson FM.
    Biochem Biophys Res Commun; 1998 Jun 29; 247(3):644-53. PubMed ID: 9647747
    [Abstract] [Full Text] [Related]

  • 6. Identification of genes and gene ontology processes critical to skin papilloma development in Tg.AC transgenic mice.
    Dang H, Trempus C, Malarkey DE, Wei SJ, Humble M, Morris RJ, Tennant RW.
    Mol Carcinog; 2006 Feb 29; 45(2):126-40. PubMed ID: 16329151
    [Abstract] [Full Text] [Related]

  • 7. Decreases in phorbol ester-induced papilloma development in v-Ha-ras transgenic TG.AC mice during reduced gene dosage of bcl-2.
    Trempus CS, Haseman JK, Tennant RW.
    Mol Carcinog; 1997 Sep 29; 20(1):68-77. PubMed ID: 9328437
    [Abstract] [Full Text] [Related]

  • 8. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
    Ridd K, Zhang SD, Edwards RE, Davies R, Greaves P, Wolfreys A, Smith AG, Gant TW.
    Carcinogenesis; 2006 Aug 29; 27(8):1556-66. PubMed ID: 16537558
    [Abstract] [Full Text] [Related]

  • 9. Focal transgene expression associated with papilloma development in v-Ha-ras-transgenic TG.AC mice.
    Hansen LA, Tennant R.
    Mol Carcinog; 1994 Mar 29; 9(3):143-54. PubMed ID: 7908201
    [Abstract] [Full Text] [Related]

  • 10. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ, Liefer KM, Greenhalgh DA, Roop DR.
    Mol Carcinog; 1999 Dec 29; 26(4):305-11. PubMed ID: 10569807
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM, Florell SR, Hanks AN, Alexander A, Diedrich MJ, Altieri DC, Grossman D.
    Cancer Res; 2003 Feb 01; 63(3):567-72. PubMed ID: 12566297
    [Abstract] [Full Text] [Related]

  • 14. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL.
    Cancer Res; 1996 Dec 01; 56(23):5391-6. PubMed ID: 8968091
    [Abstract] [Full Text] [Related]

  • 15. Loss of critical palindromic transgene promoter sequence in chemically induced Tg.AC mouse skin papillomas expressing transgene-derived mRNA.
    Thompson KL, Rosenzweig BA, Honchel R, Cannon RE, Blanchard KT, Stoll RE, Sistare FD.
    Mol Carcinog; 2001 Dec 01; 32(4):176-86. PubMed ID: 11746829
    [Abstract] [Full Text] [Related]

  • 16. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development.
    Larcher F, Murillas R, Bolontrade M, Conti CJ, Jorcano JL.
    Oncogene; 1998 Jul 23; 17(3):303-11. PubMed ID: 9690512
    [Abstract] [Full Text] [Related]

  • 17. Topical application of representative multifunctional acrylates produced proliferative and inflammatory lesions in F344/N rats and B6C3F1 mice, and squamous cell neoplasms in Tg.AC mice.
    Doi AM, Hailey JR, Hejtmancik M, Toft JD, Vallant M, Chhabra RS.
    Toxicol Pathol; 2005 Jul 23; 33(6):631-40. PubMed ID: 16176922
    [Abstract] [Full Text] [Related]

  • 18. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
    Wang XJ, Greenhalgh DA, Jiang A, He D, Zhong L, Medina D, Brinkley BR, Roop DR.
    Oncogene; 1998 Jul 09; 17(1):35-45. PubMed ID: 9671312
    [Abstract] [Full Text] [Related]

  • 19. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M, Pazzaglia S, Tanori M, Rebessi S, Di Majo V, Covelli V, Saran A.
    Mutat Res; 2004 Apr 14; 548(1-2):35-45. PubMed ID: 15063134
    [Abstract] [Full Text] [Related]

  • 20. Cytogenetic analysis of malignant skin tumors induced in chemically treated TG-AC transgenic mice.
    French JE, Libbus BL, Hansen L, Spalding J, Tice RR, Mahler J, Tennant RW.
    Mol Carcinog; 1994 Dec 14; 11(4):215-26. PubMed ID: 7999263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.